CN203662832U - Nasal cavity haemostat - Google Patents
Nasal cavity haemostat Download PDFInfo
- Publication number
- CN203662832U CN203662832U CN201320771266.7U CN201320771266U CN203662832U CN 203662832 U CN203662832 U CN 203662832U CN 201320771266 U CN201320771266 U CN 201320771266U CN 203662832 U CN203662832 U CN 203662832U
- Authority
- CN
- China
- Prior art keywords
- hemostasis
- alginate
- sleeve
- nasal cavity
- supporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003928 nasal cavity Anatomy 0.000 title abstract description 10
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229940072056 alginate Drugs 0.000 claims abstract description 22
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 22
- 229920000615 alginic acid Polymers 0.000 claims abstract description 22
- 239000011248 coating agent Substances 0.000 claims abstract description 7
- 238000000576 coating method Methods 0.000 claims abstract description 7
- 239000002874 hemostatic agent Substances 0.000 claims description 24
- 239000004744 fabric Substances 0.000 claims description 6
- 239000010409 thin film Substances 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 235000010410 calcium alginate Nutrition 0.000 claims description 5
- 229960002681 calcium alginate Drugs 0.000 claims description 5
- 239000000648 calcium alginate Substances 0.000 claims description 5
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- 230000023597 hemostasis Effects 0.000 abstract description 28
- 208000027418 Wounds and injury Diseases 0.000 abstract description 10
- 230000006835 compression Effects 0.000 abstract description 10
- 238000007906 compression Methods 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 5
- 230000007547 defect Effects 0.000 abstract description 3
- 208000014674 injury Diseases 0.000 abstract 2
- 239000004745 nonwoven fabric Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 8
- 230000000025 haemostatic effect Effects 0.000 description 5
- 230000002439 hemostatic effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010060964 Arterial haemorrhage Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model belongs to a nasal cavity haemostat in the field of medical apparatuses and instruments. A columnar supporting body (1) is wrapped by a hemostasis sleeve (2) to form the nasal cavity haemostat, the hemostasis sleeve (2) is an alginate coating sleeve, an alginate film sleeve or an alginate non-woven fabric sleeve. The defect that an existing nasal cavity haemostat only depending on hemostasis by compression is poor in hemostasis effect, complicated in structure and difficult to operate and easily causes secondary injury is overcome. The nasal cavity haemostat is simple in structure, low in cost and convenient to use, meanwhile has functions of hemostasis by compression, chemical hemostasis and biological hemostasis and can avoid secondary injury.
Description
Affiliated technical field
This utility model relates to medical instruments field, is specially a kind of nosal hemostat.
Background technology
Nasal bleeding is common sight, conventionally adopts that cotton balls, expansion sponge are sucked blood, imbibition, hemostasis, effectively protects wound.But because compressing dynamics is inadequate, not good to small arterial hemorrhage haemostatic effect, in the time extracting and wound adhesion friction cause pain, make patient's endurable, also easily cause the secondary damage of wound.China CN2865576 patent discloses a kind of biological expansion nasal cavity hemostatic sponge, and this sponge is made up of collagen protein, after chance blood, excites biologically active pdgf, promote platelet aggregation and release, form thrombosis hemostasis, but sponge needs to compress voluntarily before using, operation inconvenience, easily pollutes, and is difficult for debridement.China's CN 2348782Y patent discloses a kind of expansion type hemostat for nasal-cavity, adopts hemostatic gauze parcel swelling bag, and when use, injected water reaches the object of hemostasis by compression by capsule expansion, but complex structure is not easy to operate, only plays the effect of hemostasis by compression.China's CN 201346223Y patent discloses a kind of swelling stanch nose plug, adopt soluble stanching gauze parcel expansion sponge, but soluble stanching gauze only plays buffer action, remains and only relies on oppressive force hemostasis, and hemostasis is slow, poor effect.
Summary of the invention
The purpose of this utility model is only to rely on oppressive force hemostasis to cause haemostatic effect not good in order to overcome existing nosal hemostat, complex structure, not easy to operate, easily cause the defect of secondary damage, provide a kind of simple in structure, with low cost, easy to use, possess hemostasis by compression, chemistry hemostasis and the triple hemostatic functions of biological hemostasis simultaneously, can avoid the nosal hemostat of secondary damage.
The purpose of this utility model realizes by following technical proposals:
Nosal hemostat of the present utility model, is characterized in that forming nosal hemostat by pillar support body (1) upper parcel hemostasia sleeve (2), and described hemostasia sleeve (2) is alginate coating cover, alginate thin-film covering or alginate nonwoven cloth case.
In such scheme, described supporter (1) is air bag, solid sponge expander or hollow sponge expander, and supporter (1) is cylindrical, square column type or one large one small important actor shape.
In such scheme, described supporter (1) is with bracing wire (4), and described hemostasia sleeve (2) is with bracing wire (3).
In such scheme, described alginate are calcium alginate or Zinc alginate.
Use procedure of the present utility model is as follows:
Nosal hemostat of the present utility model is filled in to nasal cavity, inject the liquid such as air, water and make airbag inflation, or by absorbing water, blood or body fluid etc., sponge expander is expanded, make supporter fully clog nasal cavity tract, and the hemostasia sleeve that can make to be wrapped on supporter fully contacts with wound very soon, discharge Ca
2+, promote the formation of thrombokinase, reach quick-acting haemostatic powder, and have effect antibacterial and promotion wound healing.Meanwhile, after air bag or sponge expander expand, there is good hemostasis by compression effect.After hemostasis completes, first take out supporter by bracing wire, then use normal saline moistening hemostasia sleeve, then take out hemostasia sleeve by bracing wire, can effectively avoid the risk of wound secondary damage.
The utlity model has following advantage: can be used for epistaxis and nasal cavity, nasal sinuses postoperation hemostatic, rapidly, moisturizing, promotes that wound heals early in hemostasis, adhesion wound surface, easy cleaning, and there is bacteriostasis, there is again the function of expansion hemostasis by compression simultaneously, make this utility model there is hemostasis by compression, chemistry hemostasis and the triple haemostatic effects of biological hemostasis and bacteriostasis simultaneously, processing ease, quick, alleviates patient's pain, can effectively prevent wound secondary damage.
Therefore, this utility model has overcome existing nosal hemostat and has only relied on hemostasis by compression to cause haemostatic effect not good, complex structure, not easy to operate, easily cause the defect of secondary damage, the nosal hemostat providing is simple in structure, with low cost, easy to use, possess hemostasis by compression, chemistry hemostasis and the triple hemostatic functions of biological hemostasis simultaneously, can avoid secondary damage.
Brief description of the drawings
Fig. 1 is the schematic diagram of this utility model supporter while being sponge expander.
Fig. 2 is the schematic diagram of this utility model supporter while being air bag.
In accompanying drawing, the implication of each numeral is: 1: supporter; 2: hemostasia sleeve; 3: hemostasia sleeve bracing wire; 4: supporter bracing wire.
Detailed description of the invention
Be described in further detail this utility model below in conjunction with drawings and Examples, but this utility model is not limited only to described embodiment.
Embodiment mono-
The nosal hemostat that this is routine, as shown in Figure 1, forms nosal hemostat by wrapping up hemostasia sleeve 2 on pillar support body 1, and described hemostasia sleeve 2 is alginate thin-film covering.Supporter 1 is the solid sponge expander of square column type, supporter 1 with bracing wire 4 and hemostasia sleeve 2 with bracing wire 3.Alginate thin-film covering is calcium alginate thin-film covering or Zinc alginate thin-film covering.
Embodiment bis-
The nosal hemostat that this is routine, except hemostasia sleeve 2 is alginate nonwoven cloth case, all the other are with embodiment mono-.Alginate nonwoven cloth case is calcium alginate nonwoven cloth case or Zinc alginate nonwoven cloth case.
Embodiment tri-
The nosal hemostat that this is routine, except supporter 1 is one large one small round platform cylindricality air bag, all the other are with embodiment mono-.
Embodiment tetra-
The nosal hemostat that this is routine, except supporter 1 is cylindrical, massive sponge expander, hemostasia sleeve 2 is alginate coating cover, and hemostasia sleeve 2 is not with outside bracing wire, and all the other are with embodiment mono-.Alginate coating cover is calcium alginate coating cover or Zinc alginate coating cover.
Embodiment five
The nosal hemostat that this is routine, as shown in Figure 2, except supporter 1 is cylindrical air bag, all the other are with embodiment mono-.
Embodiment six
The nosal hemostat that this is routine, except supporter 1 is the one large one small solid sponge expander of round platform cylindricality, all the other are with embodiment bis-.
Embodiment seven
The nosal hemostat that this is routine, except supporter 1 is cylinder type hollow sponge expander, all the other are with embodiment bis-.
Embodiment eight
The nosal hemostat that this is routine, except supporter 1 is the one large one small hollow sponge expander of round platform cylindricality, all the other are with embodiment bis-.
Claims (4)
1. a nosal hemostat, is characterized in that forming nosal hemostat by pillar support body (1) upper parcel hemostasia sleeve (2), and described hemostasia sleeve (2) is alginate coating cover, alginate thin-film covering or alginate nonwoven cloth case.
2. nosal hemostat according to claim 1, is characterized in that described supporter (1) is air bag, solid sponge expander or hollow sponge expander, and supporter (1) is cylindrical, square column type or one large one small important actor shape.
3. nosal hemostat according to claim 1, is characterized in that described supporter (1) is with bracing wire (4), and described hemostasia sleeve (2) is with bracing wire (3).
4. nosal hemostat according to claim 1, is characterized in that described alginate are calcium alginate or Zinc alginate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320771266.7U CN203662832U (en) | 2013-12-01 | 2013-12-01 | Nasal cavity haemostat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320771266.7U CN203662832U (en) | 2013-12-01 | 2013-12-01 | Nasal cavity haemostat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203662832U true CN203662832U (en) | 2014-06-25 |
Family
ID=50959173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320771266.7U Expired - Lifetime CN203662832U (en) | 2013-12-01 | 2013-12-01 | Nasal cavity haemostat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203662832U (en) |
-
2013
- 2013-12-01 CN CN201320771266.7U patent/CN203662832U/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20170118198A (en) | Hemostatic Compositions and Hemostasis Devices (Mutants) | |
| CN205433799U (en) | First aid is with device that stanchs fast | |
| CN108042838B (en) | Preparation method of antioxidant nanofiber electrospun membrane medical dressing | |
| CN201350088Y (en) | Hemostatic bar for inferior meatus | |
| JP2017140231A (en) | Hemostatic material and wound coating material | |
| CN103480032B (en) | A kind of argentiferous plural gel dressing and preparation method thereof | |
| CN203662831U (en) | Cavity expansion haemostat | |
| CN204016935U (en) | A kind of medical bio magnetic dressing pastes | |
| CN203662832U (en) | Nasal cavity haemostat | |
| CN204147173U (en) | The compound dressing of a kind of activated carbon fiber | |
| CN202283306U (en) | Band-aid for simple wound | |
| CN202960940U (en) | Surgical anti-adhesive absorbent gauze | |
| CN203042642U (en) | Water-soluble chitosan woundplast | |
| CN204839932U (en) | Scar dressing | |
| CN201631278U (en) | Physical hemostat | |
| CN104001220B (en) | A kind of skin regeneration material and preparation method thereof | |
| CN204797929U (en) | Medical hemostasis by compression is applied ointment or plaster | |
| CN205849503U (en) | A kind of nosal hemostat | |
| CN203885716U (en) | Self-adhesive alginate applying patch | |
| CN102872303B (en) | Resina draconis application paster as well as preparation and detection methods | |
| CN202505417U (en) | Hemostasis nose tampon | |
| CN103520765A (en) | Method for preparing wound hemostasis dressing | |
| CN202173512U (en) | Medical pressurized dressing | |
| CN206334017U (en) | A kind of taper anorectum department clogs dressing | |
| CN206526074U (en) | Venipuncture point hemostasis by compression is pasted |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20140625 |